Australia's universal public insurance scheme. It subsidises GP and medical services through the Medicare Benefits Schedule (MBS) - the list of services and the rebate paid for each - and, jointly funded with the states, provides free treatment in public hospitals. Medicare is funded from general Commonwealth taxation plus the Medicare Levy (2 per cent of taxable income for most taxpayers).

What is the Pharmaceutical Benefits Scheme?

Subsidises prescription medicines so patients pay a capped co-payment rather than the full price; safety nets further reduce cost once a patient passes an annual threshold. The PBS is a large and growing Commonwealth cost as new high-price medicines are listed.

What is private health insurance?

Funds private hospital care and, through extras/ancillary cover, some dental and allied health. It is funded by members' premiums, partly offset by the means-tested private health insurance rebate. Two policy levers push people toward private cover to take pressure off the public system: the Medicare Levy Surcharge (an extra 1-1.5 per cent on higher earners who do not hold private hospital cover) and Lifetime Health Cover loading (a premium loading for taking cover later in life).

What are commonwealth-funded programs?

Beyond the MBS and PBS, the Commonwealth funds national prevention and population-health programs - the National Immunisation Program, cancer-screening programs (BreastScreen Australia, the National Bowel Cancer Screening Program), and Aboriginal and Torres Strait Islander health funding - and provides activity-based grants to states for public hospitals.

What is use the three lenses as your spine?

Sustainability, access, equity - then add the move that lifts the answer: the treatment-prevention balance and the future-population point. State explicitly that prevention is only about 2% of spend and that today's prevention is tomorrow's avoided treatment cost.

What is anchor with a dated statistic?

Replace "the government pays for most health" with "government funds about 70% of health and individuals about 14% out-of-pocket (AIHW, 2022-23)", or "prevention is only about 2% of total health spend". A figure WITH a year and source earns marks a vague claim cannot.

What is read an expenditure chart like a scientist?

For a data/stimulus item, first DESCRIBE (which source/category is largest, the figures, the government vs non-government split), then EXPLAIN with the funding framework, then say what it IMPLIES for access or equity (a 14% out-of-pocket share signals a regressive cost that threatens equity).

§-Syllabus dot point

NSWHealth and Movement ScienceSyllabus dot point

How does the way Australia spends on health affect the health of current and future populations?

Analyse health expenditure and its impact on the health of current and future populations, including the balance between treatment and prevention, and the sustainability, access and equity of funding arrangements

A focused HSC Health and Movement Science answer on health expenditure. Covers treatment versus prevention spending, sustainability, access and equity, and the main funding arrangements (Medicare, the MBS and PBS, private health insurance, and Commonwealth-funded programs), with current AIHW-style figures.

Generated by Claude Opus 4.810 min answerUpdated 2026-06-28

Reviewed by: AI editorial process; not yet individually human-reviewed

Have a quick question? Jump to the Q&A page

Quick answer

Health expenditure is the total money spent on health by government and non-government sources; in Australia government funds about 70% (Commonwealth about 43%, states about 27%), individuals about 14% out-of-pocket and private health insurance about 9% (AIHW, 2022-23). Spending is heavily weighted to treatment (hospitals about 40%) with only about 2% on prevention. The arrangements - Medicare, the MBS and PBS, private health insurance, and Commonwealth programs, balanced by the Medicare Levy, the Medicare Levy Surcharge and the PHI rebate - deliver strong access but face sustainability pressure (ageing, chronic disease, about 10% of GDP) and equity gaps (regressive out-of-pocket costs). Shifting spend toward prevention is the key lever for the health and affordability of future populations.

Jump to a section

What this sub-topic is asking
The answer
Examples in context
Try this

What this sub-topic is asking

NESA wants you to explain how Australia funds health, read the balance between treatment and prevention spending, and analyse what the current arrangements mean for sustainability, access and equity - for both today's population and future populations. Strong responses name the funding sources (Medicare, the MBS and PBS, private health insurance, Commonwealth programs), quote current figures with a year, and reach a calibrated judgement rather than just describing what Medicare covers.

The answer

Health expenditure is the total money spent on health goods and services in a period, by governments (Commonwealth and state/territory) and non-government sources (individuals, private health insurers) combined. The key analytical questions are: where does the money come from, where does it go (treatment vs prevention), and is the arrangement sustainable, accessible and equitable now and into the future?

Where the health dollar comes from

Government is the dominant funder. The clearest way to hold the mix is as the share each source contributes to total health spending.

In round numbers (AIHW Health Expenditure Australia, 2022-23): the Commonwealth funds about 43 per cent, state and territory governments about 27 per cent, individuals out-of-pocket about 14 per cent, private health insurance about 9 per cent, and other non-government sources about 7 per cent. So government funds roughly 70 per cent of health, and out-of-pocket payment by individuals is the single largest non-government share. Total health spending is on the order of 10 per cent of GDP. (Treat exact percentages as current AIHW estimates - flag for re-verification against the latest release.)

The main funding arrangements

Medicare: Australia's universal public insurance scheme. It subsidises GP and medical services through the Medicare Benefits Schedule (MBS) - the list of services and the rebate paid for each - and, jointly funded with the states, provides free treatment in public hospitals. Medicare is funded from general Commonwealth taxation plus the Medicare Levy (2 per cent of taxable income for most taxpayers).
The Pharmaceutical Benefits Scheme (PBS): Subsidises prescription medicines so patients pay a capped co-payment rather than the full price; safety nets further reduce cost once a patient passes an annual threshold. The PBS is a large and growing Commonwealth cost as new high-price medicines are listed.
Private health insurance (PHI): Funds private hospital care and, through extras/ancillary cover, some dental and allied health. It is funded by members' premiums, partly offset by the means-tested private health insurance rebate. Two policy levers push people toward private cover to take pressure off the public system: the Medicare Levy Surcharge (an extra 1-1.5 per cent on higher earners who do not hold private hospital cover) and Lifetime Health Cover loading (a premium loading for taking cover later in life).
Commonwealth-funded programs: Beyond the MBS and PBS, the Commonwealth funds national prevention and population-health programs - the National Immunisation Program, cancer-screening programs (BreastScreen Australia, the National Bowel Cancer Screening Program), and Aboriginal and Torres Strait Islander health funding - and provides activity-based grants to states for public hospitals.

Treatment versus prevention - where the money goes

The other half of the analysis is where the dollar is spent. Australia's spending is heavily weighted to treatment rather than prevention.

Hospitals are the single biggest category (around 40 per cent of recurrent spend), and once primary care and medicines are added the system is overwhelmingly curative. Dedicated public-health and prevention spending sits at only about 2 per cent of total health expenditure (AIHW). Most money therefore reaches people after they are already unwell.

Sustainability, access and equity

These three lenses are how NESA wants you to judge the arrangements.

Sustainability. Health spending is a large and rising share of GDP (on the order of 10 per cent). An ageing population and a rising chronic-disease burden push treatment demand upward, while new high-cost medicines and technologies add expense. The treatment-heavy balance is affordable in the short term but stores up future demand, which is why prevention is framed as an investment in long-run sustainability.
Access. Universal Medicare and the PBS remove most of the price barrier at the point of care, which is the great strength of the arrangements - broad access regardless of income. The public-private levers (the Medicare Levy Surcharge, the PHI rebate) aim to keep both systems usable.
Equity. Because about 14 per cent of spending is out-of-pocket and out-of-pocket cost is regressive, gap fees, most dental and most allied health fall hardest on lower-income and chronically ill people, producing cost-related deferral of care. Equity adjustments (bulk-billing incentives, PBS safety nets, concession arrangements) narrow but do not close this.

The future-population point

The treatment-prevention balance matters most for future populations. Today's prevention spending is tomorrow's avoided treatment cost: under-investing upstream now means more preventable chronic disease later, raising future treatment costs and worsening outcomes - a costlier, sicker future population. Rebalancing even a small share toward immunisation, screening and risk-factor programs improves both the future health profile and the affordability of the system.

Worked exam answers

Worked example 1 - a data/stimulus response (5 marks)

Question. A described dataset shows the share of Australian health spending by source: Commonwealth about 43%, states about 27%, out-of-pocket about 14%, private health insurance about 9%, other about 7%. Describe what the data show and explain one equity implication.

Model answer. Government is the dominant funder: the Commonwealth (about 43%) and the states (about 27%) together fund roughly 70% of health, leaving non-government sources funding about 30%, of which the out-of-pocket share (about 14%) is the largest. The key equity implication follows from that out-of-pocket share: because roughly $1 in every $7 is paid directly by patients - and out-of-pocket cost (specialist gap fees, most dental, most allied health) is regressive, taking a larger slice of a low income - the cost falls hardest on lower-income and chronically ill people. The AIHW has reported cost-related deferral of GP visits, dental care and prescriptions. So despite a large government share, the funding mix still produces unequal access along income lines unless equity adjustments such as bulk-billing incentives and PBS safety nets offset it.

Marker's note: about 2 marks for an accurate description with figures and the government/non-government split, about 2 marks for an equity implication correctly tied to the out-of-pocket share, and 1 mark for a real consequence (cost-related deferral) or an offsetting mechanism. A description with no implication, or an equity claim that never refers to the data, caps at 3.

Worked example 2 - an extended-response paragraph (analyse)

Question (paragraph only). Analyse how the treatment-prevention balance in Australia's health spending affects future populations. Write one body paragraph.

Model paragraph. The clearest long-run risk in Australia's expenditure arrangements is not where the money comes from but where it goes. Hospitals alone absorb roughly 40% of recurrent health spending, and once primary care and medicines are added the system is overwhelmingly curative; dedicated public-health and prevention spending sits at only around 2% of total health expenditure (AIHW). At the same time the disease burden is shifting toward chronic, largely preventable conditions - cardiovascular disease, type 2 diabetes and obesity-related illness - and the population is ageing, both of which push treatment demand upward, with total health spending already on the order of 10% of GDP. The cause-and-effect is direct: money spent downstream treats illness that better-funded prevention could have averted, so each dollar not invested upstream tends to return later as a more expensive admission. The treatment-prevention balance is therefore a sustainability question for future populations specifically: a treatment-dominated mix can keep current patients well while quietly enlarging the chronic-disease load the next generation must fund, which is why rebalancing even a small share toward prevention improves both future health and affordability.

Marker's note: markers reward a thesis that ANALYSES (links the balance to future cost and health) rather than defining treatment and prevention; the balance stated with figures carrying a source (hospitals about 40%, prevention about 2%, spending about 10% of GDP); an explicit cause-and-effect chain to the future population; and a forward-looking judgement. Two definitions with no future link stays mid-band.

Worked example 3 - a short-answer response (4 marks)

Question. Outline how the Medicare Levy, the Medicare Levy Surcharge and the private health insurance rebate each help keep the health system sustainable.

Model answer. The Medicare Levy (2% of taxable income for most taxpayers) spreads the cost of universal care across the working population by income, giving Medicare a broad, income-linked funding base. The Medicare Levy Surcharge adds an extra 1-1.5% for higher-income earners who do not hold private hospital cover, which pushes higher earners toward private cover and so eases demand on public hospitals. The private health insurance rebate (a means-tested subsidy on premiums), with Lifetime Health Cover loading, encourages people to take and keep private cover earlier, broadening the insured risk pool and helping hold premiums down. Together the three levers share the load between the public and private systems so neither becomes unsustainable.

Marker's note: 1 mark for each lever correctly explained in terms of sustainability (spreading cost / shifting demand to private / broadening the pool), plus 1 mark for the overall point that they balance the public-private load. Naming the levers without their purpose caps the response.

Common traps

Describing Medicare instead of analysing the spending: "Medicare covers GP visits and hospitals" is background; the question wants the funding mix, the treatment-prevention balance, and a judgement on sustainability, access and equity.
Quoting figures with no year or source: "The government pays most of it" is weak; "government funds about 70% of health, individuals about 14% out-of-pocket (AIHW, 2022-23)" earns marks.
Ignoring prevention: Many answers stop at "treatment is expensive". The high-value insight is that prevention is only about 2% of spend, and that under-investing upstream raises future cost - the future-population link.
Treating sustainability, access and equity as one idea: They pull in different directions (e.g. out-of-pocket costs can ease the public budget but worsen equity). Strong answers separate the three lenses and weigh the trade-off.
Confusing the levers: The Medicare Levy funds Medicare; the Medicare Levy Surcharge penalises higher earners without private cover; the PHI rebate subsidises premiums. Do not merge them.

Exam technique

Match the command word to the depth: "Outline/describe" wants the funding sources or the spending pattern with a figure each; "explain" wants a cause-and-effect chain (e.g. low prevention spend to higher future chronic-disease cost); "analyse/assess/evaluate" wants you to weigh sustainability, access and equity against each other and reach a judgement. Listing what Medicare covers for an "analyse" question caps your band.
Use the three lenses as your spine: Sustainability, access, equity - then add the move that lifts the answer: the treatment-prevention balance and the future-population point. State explicitly that prevention is only about 2% of spend and that today's prevention is tomorrow's avoided treatment cost.
Anchor with a dated statistic: Replace "the government pays for most health" with "government funds about 70% of health and individuals about 14% out-of-pocket (AIHW, 2022-23)", or "prevention is only about 2% of total health spend". A figure WITH a year and source earns marks a vague claim cannot.
Read an expenditure chart like a scientist: For a data/stimulus item, first DESCRIBE (which source/category is largest, the figures, the government vs non-government split), then EXPLAIN with the funding framework, then say what it IMPLIES for access or equity (a 14% out-of-pocket share signals a regressive cost that threatens equity).

In plain English

Think of paying for the country's health like running a giant shared household. Most of the bills are paid by the "parents" - the federal and state governments - who between them cover about 70 cents in every dollar. The rest comes out of people's own pockets at the checkout (about 14 cents), or through a private "insurance club" you can join (about 9 cents) that the government also chips in to help pay for. Medicare is the rule that says everyone in the house gets to see a doctor and use a public hospital without being handed a huge bill, and it is paid for by a small slice taken from everyone's pay packet (the Medicare Levy). The PBS is the deal that makes medicines cheaper at the chemist. Now the important bit: almost all the money goes on fixing people once they are already sick - hospitals alone eat about 40 cents in the dollar - and only about 2 cents goes on stopping people getting sick in the first place (vaccines, screening, anti-smoking campaigns). That is a bit like spending almost everything on a plumber to mop up floods and almost nothing on fixing the leaky pipe. It mostly works for the people in the house today, but if you never fix the pipe, the floods (and the bills) just get bigger for whoever lives here next. That is why experts keep arguing we should spend a little more "upstream" on prevention - it is cheaper and healthier in the long run.

Examples in context

Example 1. The Pharmaceutical Benefits Scheme (PBS). The PBS is the canonical example of how a funding arrangement shapes both access and sustainability. By subsidising prescription medicines down to a capped co-payment (with safety nets for high-need users), it removes a major financial barrier - a patient pays a small fraction of the true price of many medicines. But it is also one of the fastest-growing Commonwealth health costs, because each new high-price medicine listed (for cancer, hepatitis C, rare diseases) adds ongoing expense. The PBS therefore illustrates the central tension of the whole topic: arrangements designed to protect access must also be managed for long-run sustainability, which is why listings are assessed for cost-effectiveness before approval.

Example 2. The 2% prevention slice. The most quotable single fact in this topic is that Australia spends only about 2% of total health expenditure on dedicated public health and prevention, while hospitals absorb around 40%. This is the structural argument for "investing upstream": public-health measures such as the National Immunisation Program, BreastScreen and bowel-cancer screening, and tobacco control deliver high returns by preventing disease before the expensive treatment stage. For HMS answers it is the clearest evidence that the current expenditure balance protects current patients but under-invests in the health of future populations.

Try this

Q1. Identify the four main sources that fund Australian health and state briefly what each pays for. [4 marks]

Cue. Commonwealth (MBS, PBS, PHI rebate, hospital grants); states/territories (run public hospitals, ambulance, community/prevention); individuals (out-of-pocket gap fees, most dental, allied health); private health insurance (private hospital, extras). Government funds about 70%; out-of-pocket about 14% (AIHW, 2022-23).

Q2. Explain how the balance between treatment and prevention spending affects the health of future populations. [6 marks]

Cue. State the balance (hospitals about 40% of recurrent spend; prevention only about 2%). Build the cause-and-effect: under-investing upstream means more preventable chronic disease later, higher future treatment cost, worse outcomes. Ageing population and chronic-disease burden push demand up. Conclude that prevention is investment in future sustainability.

Q3. Analyse how Australia's health expenditure arrangements affect the sustainability, access and equity of the system for current and future populations. [12 marks]

Cue. Use the three lenses as the spine. Funding mix supports access but loads cost unevenly (out-of-pocket about 14% is regressive). Treatment-heavy balance (prevention about 2%) threatens future sustainability as the population ages and spend approaches 10% of GDP. Public-private levers (Medicare Levy, Medicare Levy Surcharge, PHI rebate) share the load. Reach a calibrated judgement: strong access and reasonable equity by design, but rebalancing toward prevention is needed for future populations.

Practice questions

Original practice questions graded from foundation to exam level, each with a full worked solution. Try them before revealing the solution.

foundation3 marksDefine 'health expenditure', and distinguish between 'treatment' (curative) spending and 'prevention' (preventive) spending, giving one Australian example of each.

Show worked solution →

Definition (1 mark). Health expenditure is the total amount of money spent on health goods and services in a period - by governments (Commonwealth and state/territory) and non-government sources (individuals, private health insurers) combined.

Treatment vs prevention (2 marks). Treatment (curative) spending pays to diagnose and manage illness once it has occurred - e.g. a hospital admission, a Medicare-rebated GP consultation, or a Pharmaceutical Benefits Scheme (PBS) medicine. Prevention (preventive) spending acts before illness to stop it occurring or progressing - e.g. the National Immunisation Program, cancer screening programs (BreastScreen, the National Bowel Cancer Screening Program), or anti-smoking campaigns.

Award 1 mark for the definition, 1 mark for the contrast (after illness vs before illness), and 1 mark for one fitting Australian example on each side. A definition with no examples, or examples with no contrast, scores partial.

foundation4 marksIdentify the four main sources that fund health in Australia, and for each state briefly what it pays for.

Show worked solution →

Award 1 mark per source correctly named WITH what it funds.

Commonwealth (federal) government - 1 mark: The largest single funder. Pays Medicare rebates (the Medicare Benefits Schedule, MBS), the PBS, the private health insurance rebate, and grants to states for public hospitals.
State and territory governments - 1 mark: Co-fund and run public hospitals, ambulance and community health services, and much of public health/prevention.
Individuals (out-of-pocket) - 1 mark: Gap fees, most dental, many allied-health services, over-the-counter medicines and non-subsidised costs - roughly $1 in every $7 of health spending (about 14 per cent; AIHW, 2022-23).
Private health insurance - 1 mark: Funds private hospital care, some dental and allied health (extras/ancillary cover), and is itself subsidised by the Commonwealth rebate.

Full marks need all four sources named with a correct funding role. (Figures: AIHW Health Expenditure Australia, 2022-23; treat as current published estimates.)

core5 marksA described dataset (owned, ExamExplained, modelled on AIHW Health Expenditure Australia 2022-23) shows where Australia's health dollar comes from: Commonwealth government about 43%, state and territory governments about 27%, individuals (out-of-pocket) about 14%, private health insurance about 9%, and other non-government sources about 7%. Describe what the data show, and explain one implication of this funding mix for equity of access.

Show worked solution →

A 5-mark "describe and explain" rewards (i) an accurate reading of the data with figures, and (ii) a reasoned equity implication, not just a restatement.

Describe (about 2 marks). Government is the dominant funder: the Commonwealth (about 43%) and the states/territories (about 27%) together fund roughly 70% of health, leaving non-government sources (out-of-pocket about 14%, private health insurance about 9%, other about 7%) funding the remaining roughly 30%. Out-of-pocket spending by individuals is the single largest non-government share. Quote at least the government total and the out-of-pocket figure.

Explain an equity implication (about 3 marks). Because about 14% of spending is paid directly out-of-pocket, cost falls hardest on those least able to absorb it. Out-of-pocket costs (specialist gap fees, most dental, most allied health) are regressive - they take a larger share of a low income - so lower-income and chronically ill patients are more likely to delay or skip care. The AIHW has reported cost-related deferral of GP visits, dental care and prescriptions. This means the funding mix, despite a large government share, still produces unequal access along income lines unless equity adjustments (bulk-billing incentives, PBS safety nets, concession arrangements) offset it.

Marking spine: accurate description with figures and the government/non-government split (2), a correctly reasoned equity implication tied to the out-of-pocket share (2), and a link to a real consequence such as cost-related deferral or a safety-net mechanism (1). A pure description with no implication, or an equity claim that never refers to the data, caps at 3. (Figures are an owned ExamExplained dataset modelled on AIHW Health Expenditure Australia 2022-23; treat as illustrative.)

core6 marksExplain how the current balance between treatment spending and prevention spending in Australia affects the health of future populations.

Show worked solution →

A 6-mark "explain... affects" needs a causal chain from the spending balance to future health outcomes, not just two definitions.

State the balance (about 1-2 marks): Australia spends the large majority of the health dollar on treatment - hospitals are the single biggest category (roughly 40% of recurrent spend) and primary care and medicines add more curative cost - while dedicated public-health/prevention spending is a small slice, on the order of only about 2% of total health expenditure (AIHW). Most money therefore reaches people after they are already unwell.
Explain the future-population effect (about 3-4 marks): The disease burden is increasingly chronic and preventable (cardiovascular disease, type 2 diabetes, many cancers, obesity-related illness), and these conditions are driven by modifiable risk factors. Under-investing in prevention now means more people develop chronic disease later, which raises future treatment costs, lengthens hospital queues and worsens outcomes - a costlier, sicker future population. Conversely, prevention spending (immunisation, screening, tobacco control, healthy-environment policy) tends to have a high return because it stops disease before the expensive treatment stage. So the current treatment-heavy balance is sustainable in the short term but stores up demand, whereas shifting some spend "upstream" to prevention improves the long-run health and affordability for future populations.
Tie it together: Conclude that the balance matters because today's prevention spending is tomorrow's avoided treatment cost; a treatment-dominated mix protects current patients but can leave future populations with a larger, more expensive chronic-disease load.

Marking spine: the balance stated with at least one figure (1-2), a clear cause-and-effect chain from low prevention spend to higher future chronic-disease burden and cost (3), and a forward-looking judgement about sustainability (1). Listing "treatment is curing, prevention is preventing" with no future link stays mid-band.

core5 marksOutline how Medicare and private health insurance are funded, and explain how the Medicare Levy, the Medicare Levy Surcharge and the private health insurance rebate are designed to keep the system sustainable.

Show worked solution →

A 5-mark "outline and explain" rewards how the two are funded plus how the three policy levers protect sustainability.

Medicare funding (about 1 mark): Medicare is funded from general Commonwealth taxation plus the Medicare Levy - a levy of 2% of taxable income for most taxpayers - and delivers the universal MBS rebates and (with the states) public hospital care.
Private health insurance funding (about 1 mark): Private health insurance is funded by members' premiums, partly offset by the Commonwealth private health insurance rebate (a means-tested subsidy on premiums).
The three levers (about 3 marks): (1) The Medicare Levy spreads the cost of universal care across the working population by income. (2) The Medicare Levy Surcharge (an extra 1-1.5% on higher-income earners who do NOT hold private hospital cover) pushes higher earners to take private cover, easing demand on the public system. (3) The private health insurance rebate and Lifetime Health Cover loading encourage people to take and keep private cover earlier, broadening the insured risk pool and keeping premiums sustainable. Together these aim to balance the load between the public and private systems so neither becomes unsustainable.

Marking spine: funding sources for both correctly outlined (2), and each of the three levers explained in terms of sustainability/sharing the load between public and private (3). Naming the levers without explaining their purpose caps the response.

exam12 marksAnalyse how Australia's health expenditure arrangements affect the sustainability, access and equity of the health system for current and future populations. In your answer, refer to specific funding sources, the treatment-prevention balance, and current data.

Show worked solution →

A 12-mark "analyse" extended response needs a sustained argument that shows HOW the funding arrangements shape sustainability, access AND equity - with named funding sources, the treatment-prevention balance and current data - not a description of Medicare.

Band 6 PLAN.

Thesis: Australia's health expenditure arrangements deliver strong universal access and reasonable equity by design, but their treatment-heavy balance and reliance on out-of-pocket costs create real pressures on long-run sustainability and on equity for the worst-off - so the system is sound but not self-correcting, and its future health impact depends on rebalancing spend toward prevention.

Argument 1 - the funding mix supports access but loads cost unevenly (equity). Evidence: government funds roughly 70% of health (Commonwealth about 43%, states about 27%), with out-of-pocket about 14% and private health insurance about 9% (AIHW, 2022-23). Mechanism: universal Medicare and the PBS remove most of the price barrier, but the out-of-pocket share is regressive, so specialist gap fees, dental and allied-health costs still produce cost-related deferral concentrated among lower-income and chronically ill people - equity adjustments (bulk-billing incentives, PBS safety nets) narrow but do not close this.

Argument 2 - the treatment-prevention balance threatens future sustainability. Evidence: hospitals are the largest spending category (around 40% of recurrent spend) while dedicated prevention is only around 2% of total health expenditure (AIHW); health spending is also a large and rising share of GDP (on the order of 10%). Mechanism: an ageing population and a rising chronic-disease burden push treatment demand up; spending overwhelmingly downstream means tomorrow's preventable disease becomes tomorrow's expensive admission, so the current balance stores up future cost.

Argument 3 - the public-private levers are designed to share the load (sustainability). Evidence: the Medicare Levy (2%), the Medicare Levy Surcharge on higher earners without cover, and the private health insurance rebate. Mechanism: these levers shift some demand and cost to the private system and broaden the insured pool, easing pressure on public hospitals - but they also direct public subsidy toward private cover, which critics argue is itself an equity and value-for-money question.

Counter-weight / judgement: By international standards Australia achieves good outcomes for its spend and broad access, so the arrangements are more sustainable and equitable than many comparable systems; the honest verdict is that they protect current populations well but, without a shift toward prevention and continued attention to out-of-pocket costs, will face mounting sustainability and equity pressure for future populations.

Model paragraph (Argument 2). The clearest long-run risk in Australia's expenditure arrangements is not where the money comes from but where it goes. Hospitals alone absorb roughly 40% of recurrent health spending, and once primary care and medicines are added the system is overwhelmingly curative; dedicated public-health and prevention spending sits at only around 2% of total health expenditure (AIHW). At the same time the disease burden is shifting toward chronic, largely preventable conditions - cardiovascular disease, type 2 diabetes and obesity-related illness - and the population is ageing, both of which push treatment demand upward, with total health spending already on the order of 10% of GDP. The cause-and-effect is direct: money spent downstream treats illness that better-funded prevention could have averted, so each dollar not invested upstream tends to return later as a more expensive admission. This is why the treatment-prevention balance is a sustainability question for future populations specifically: a treatment-dominated mix can keep current patients well while quietly enlarging the chronic-disease load the next generation must fund. Rebalancing even a small share toward immunisation, screening and risk-factor programs therefore improves both the future health profile and the affordability of the system - which is the structural reform the data point to.

Marker's note: markers reward a thesis that genuinely ANALYSES (links funding arrangements to sustainability, access AND equity, and shows trade-offs) rather than describing Medicare; explicit, correct use of the funding mix and the treatment-prevention balance; CURRENT data carrying a year (the roughly 70% government share and about 14% out-of-pocket, AIHW 2022-23; hospitals about 40% of recurrent spend; prevention about 2%; spending about 10% of GDP); named levers (Medicare Levy, Medicare Levy Surcharge, private health insurance rebate, PBS); and a calibrated judgement that distinguishes current from future populations. A "what Medicare covers" description, or data with no year, cannot reach the top band.